Novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2, which originated in Wuhan (China), transformed into a worldwide pandemic. The short span associated with the spread of the virus and its varied manifestations presents a steep learning curve for many clinicians on the front-line of treatment. Cardiology is one such affected area. This paper details the signs and symptoms of cardiovascular disease resulting from COVID-19, including its proposed pathophysiology, signs and symptoms, treatments and outcomes under investigation. The consensus is that COVID-19 patients with cardiovascular injury have a shorter duration from symptom onset to deterioration, higher mortality and higher prevalence in older populations. Diagnosis and intervention for patients with underlying cardiovascular comorbidities is critical.
【저자키워드】 COVID-19, SARS-CoV-2, Cardiology, ACE-2, 【초록키워드】 Treatment, coronavirus disease, coronavirus, Mortality, cardiovascular disease, Intervention, Symptom, outcome, virus, Symptoms, Spread, Prevalence, China, Deterioration, pathophysiology, Wuhan, Patient, novel, Critical, Injury, COVID-19 patient, manifestation, symptom onset, Consensus, acute respiratory syndrome, Older, clinician, worldwide pandemic, populations, resulting, affected, caused, cardiovascular comorbidity,